World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
58
Citations
10891
World Ranking
3456
National Ranking
1364

Robert W. Buckheit publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Robert W. Buckheit sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 162 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Robert W. Buckheit D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert W. Buckheit sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 58 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Robert W. Buckheit is affiliated with ImQuest BioSciences in the United States. Their research primarily focuses on the fields of medicine, immunology and microbiology, and health professions, with particular attention to infectious diseases, microbiology, general health professions, virology, and psychiatry and mental health.

The scientist's work encompasses multiple topics including HIV/AIDS research and interventions, reproductive tract infections research, adolescent sexual and reproductive health, HIV research and treatment, and sexual function and dysfunction studies.

Key recent publications include:

  • Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: A First-In-Human Study, 2020, AIDS Research and Human Retroviruses
  • The Role of Volume in the Perceptibility of Topical Vaginal Formulations: User Sensory Perceptions and Experiences of Heterosexual Couples During Vaginal Sex, 2020, AIDS Research and Human Retroviruses
  • Designing Dual Compartment HIV Prevention Products: Women's Sensory Perceptions and Experiences of Suppositories for Rectal and Vaginal Use, 2021, AIDS Research and Human Retroviruses

The frequent publication venue for Robert W. Buckheit's work is AIDS Research and Human Retroviruses.

Frequent collaborators include:

  • Anthony S. Ham
  • Karen W. Buckheit
  • Kate M. Guthrie
  • Joseph L. Fava
  • Sara Vargas

These collaborations suggest active involvement in multidisciplinary research teams focused on HIV prevention and reproductive health.

Best Publications

  • Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.

    M R Boyd;K R Gustafson;J B McMahon;R H Shoemaker

  • The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.

    Yoel Kashman;Kirk R. Gustafson;Richard W. Fuller;John H. Cardellina

  • Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.

    Thomas Roth;Marshall L. Morningstar;Paul L. Boyer;Stephen H. Hughes

  • Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.

    Toshiyuki Mori;Barry R. O'Keefe;Raymond C. Sowder;Scott Bringans

  • Circulins A and B. Novel human immunodeficiency virus (HIV)-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia.

    Kirk R. Gustafson;Raymond C. Sowder;Louis E. Henderson;Ian C. Parsons

  • Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS

    William G. Rice;Jeffrey G. Supko;Louis Malspeis;Robert W. Buckheit

  • Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion.

    Jacqueline R. Wyatt;Timothy A. Vickers;Joseph L. Roberson;Robert W. Buckheit

  • Shikonin, a Component of Chinese Herbal Medicine, Inhibits Chemokine Receptor Function and Suppresses Human Immunodeficiency Virus Type 1

    Xin Chen;Lu Yang;Ning Zhang;Jim A. Turpin

  • A Potent Novel Anti-HIV Protein from the Cultured Cyanobacterium Scytonema varium†

    Heidi R. Bokesch;Barry R. O'keefe;Tawnya C. Mckee;Lewis K. Pannell

  • In Vitro and in Vivo Characterization of a Potential Universal Placebo Designed for Use in Vaginal Microbicide Clinical Trials

    Deborah Tien;Roger L Schnaare;Feirong Kang;Gina Cohl

  • Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin

    Barry R. O'Keefe;Donald F. Smee;Jim A. Turpin;Carrie J. Saucedo

  • Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.

    T. Vickers;B.F. Baker;P.D. Cook;M. Zounes

  • Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

    J B McMahon;R J Gulakowski;O S Weislow;R J Schultz

  • Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase and human DNA polymerases alpha, beta, and gamma by the 5'-triphosphates of carbovir, 3'-azido-3'-deoxythymidine, 2',3'-dideoxyguanosine and 3'-deoxythymidine. A novel RNA template for the evaluation of antiretroviral drugs.

    W B Parker;E L White;S C Shaddix;L J Ross

  • Antiviral Activity of Hop Constituents Against a Series of DNA and RNA Viruses

    Victor E Buckwold;Richard J.H Wilson;Aysegul Nalca;Brigitte B Beer

  • Novel targets for HIV therapy.

    Warner C. Greene;Zeger Debyser;Yasuhiro Ikeda;Eric O. Freed

  • Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms.

    J B McMahon;M J Currens;R J Gulakowski;R W Buckheit

  • T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.

    J O Ojwang;R W Buckheit;Y Pommier;A Mazumder

  • Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors.

    Robert W. Buckheit;Valerie Fliakas-Boltz;W.Don Decker;Joseph L. Roberson

  • Development of a Comprehensive Human Immunodeficiency Virus Type 1 Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides

    Carol Lackman-Smith;Clay Osterling;Katherine Luckenbaugh;Marie Mankowski

  • Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV).

    Robert J Gulakowski;James B McMahon;Robert W Buckheit;Kirk R Gustafson

  • Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.

    William G. Rice;Jim A. Turpin;Mingjun Huang;David Clanton

  • Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.

    William G. Rice;Jim A. Turpin;Catherine A. Schaeffer;Lisa Graham

Frequent Co-Authors

Mark Cushman
Mark Cushman Purdue University West Lafayette
James B. McMahon
James B. McMahon National Institutes of Health
Michael R. Boyd
Michael R. Boyd National Cancer Institute
Christophe Pannecouque
Christophe Pannecouque Rega Institute for Medical Research
Erik De Clercq
Erik De Clercq Rega Institute for Medical Research
Barry R. O'Keefe
Barry R. O'Keefe National Institutes of Health
David J. Ecker
David J. Ecker Ionis Pharmaceuticals (United States)
Stephen Hughes
Stephen Hughes National Cancer Institute
Robert H. Shoemaker
Robert H. Shoemaker National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths, often requiring complementary education or certifications. For example, aspiring healthcare professionals may explore degrees linked to the functional medicine nurse role, which integrates microbiological knowledge with patient care.

For those interested in healthcare administration, becoming a Certified Professional Coder is a viable option. Understanding medical terminology, including microbiology basics, can enhance your skills and income potential as reflected in the cpc medical coding salary insights.

Microbiology students seeking to make an impact in pediatric health might also consider careers such as child specialists, where the child specialist salary reflects the field’s demand and specialization.

Importantly, online degree programs accommodate diverse backgrounds and challenges. If you have a record, some of the best degree for felons options may align with microbiology or related healthcare fields, helping you build a rewarding career while overcoming barriers.

Best Scientists Citing Robert W. Buckheit

Trending Scientists

Recently Published Articles